March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Learn about reasonable accommodation in the workplace, your rights by law as a person living with HIV, and how to take care of yourself at work.
From February 22 to February 26, 2016, approximately 4,000 scientists, clinicians, and HIV advocates from 96 countries gathered in Boston for the Conference on Retroviruses and Opportunistic Infections (CROI).